GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PMD Device Solutions AB (OSTO:PMDS) » Definitions » Short-Term Debt & Capital Lease Obligation

PMD Device Solutions AB (OSTO:PMDS) Short-Term Debt & Capital Lease Obligation : kr26.92 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is PMD Device Solutions AB Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. PMD Device Solutions AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr26.92 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. PMD Device Solutions AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr0.89 Mil.


PMD Device Solutions AB Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for PMD Device Solutions AB's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PMD Device Solutions AB Short-Term Debt & Capital Lease Obligation Chart

PMD Device Solutions AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial - - - - 4.73

PMD Device Solutions AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.73 28.64 32.94 26.92

PMD Device Solutions AB Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


PMD Device Solutions AB Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of PMD Device Solutions AB's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


PMD Device Solutions AB Business Description

Traded in Other Exchanges
N/A
Address
C/o Eversheds Sutherland Advokatbyra AB, Box 14055, Stockholm, SWE, 104 40
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.

PMD Device Solutions AB Headlines

No Headlines